Displacement of bilirubin from albumin in plasma from jaundiced newborns. An in vitro study of purified Chinese herbal constituents and sulfisoxazole

Phytotherapy Research

Volumn 25, Issue 7, 2011, Pages 1068-1072

  Soligard, Hanne Tegnander ^a   Bratlid, Dag ^a,b   Cao, Chunyu ^c   Liang, Aihua ^c   Nilsen, Odd Georg ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Bilirubin; Displacement; Herbal constituents; Newborns; Plasma; Sulfisoxazole

Indexed keywords

ALBUMIN; BILIRUBIN; HERBACEOUS AGENT; NEFERINE; NOTOGINSENOSIDE R1; SINOMENINE; SULFAFURAZOLE; TETRAHYDROPALMATINE; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; HUMAN; IN VITRO STUDY; NEWBORN; NEWBORN JAUNDICE; PLASMA PROTEIN BINDING; PROTEIN BINDING;

BILIRUBIN; BINDING SITES; BINDING, COMPETITIVE; DRUGS, CHINESE HERBAL; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; SERUM ALBUMIN; SULFISOXAZOLE;

EID: 84860411769     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3402     Document Type: Article

References (32)

1. Ahlfors CE. 2000. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 279:130-135. (Pubitemid 30165000)
2. Ahlfors CE, Wenneberg RP. 2004. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 28:334-339.
3. Andersen DH, Blanc WA, Crozier DN et al. 1956. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18:614-625.
4. Bratlid D. 1972a. The effect of free fatty acids, bile acids, and hematin on bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 30:107-112.
5. Bratlid D. 1972b. The effect of antimicrobial agents on bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 30:331-337.
6. Bratlid D. 1990. How bilirubin gets into the brain. Clin Perinatol 17:449-465. (Pubitemid 20208879)
7. Brodersen R. 1974. Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J Clin Invest 54:1353-1364.
8. Fan Z, Wu B, Liu G et al. 2007. A reviewof the pharmacology study and clinical application of rhizome corydalis. Heilongjiang Med J 20:522-524.
9. Han Y. 2005. Review on study of total saponins of panax notognseng. China Pharm 8:197-199.
10. FDA Guidelines. 2008. http://www.fda.gov/cber/gdlns/dose.htm/April 2008
11. Hu X, Zhang X, Cai H, et al. 1993. Study on pharmacokinetics of neferine in rabbit. Chin J Hosp Pharm 13:105-107.
12. Jacobsen J, Wennberg RP. 1974. Determination of unbound bilirubin in the serum of newborns. Clin Chem 20:783.
13. Liu Q, Zhou L, Li R. 1997. Review on the study of sinomenine. Chin Tradit Herb Drugs 28:247-249.
14. Long X. 2003. A review of study of sinomenine. Central South Pharmacy 1:299-301.
15. Nilsen OG, Leren P, Aakesson I et al. 1978. Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol 27:871-876. (Pubitemid 8337218)
16. Nordeng H, Havnen GC. 2004. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 13:371-380. (Pubitemid 38787156)
17. Nordeng H, Havnen GC. 2005. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand 84:26-33. (Pubitemid 40179484)
18. O'Byrne S, Barry MG, Collins WC et al. 1993. Plasma protein binding of lidocaine and warfarin in insulin-dependent and non-insulin-dependent diabetes mellitus. Clin Pharmacokinet 24:183-186. (Pubitemid 23052201)
19. Odell GB. 1959. Studies in kernicterus. I. The protein binding of bilirubin. J Clin Invest 38:823-833.
20. Odell GB. 1970. The distribution and toxicity of bilirubin. E. Mead Johnson address 1969. Pediatrics 46:16-24.
21. Pang Z, Wapg B, Wang C et al. 1995. Study on pharmacokinetics of tetrahydropalmatine in rabbit plasma. Chin J Pharm Anal 15:13-16.
22. Sha DX, Zhang ML. 2005. Determination of notoginsenoside R1, ginsenoside Rg1 and Rb1in radix notoginseng and its preparation by HPLC-ELSD. Chin J Chin Mater Med 30:112-115.
23. Sung RY, Lui S, Lo L et al. 1988. Traditional Chinese infant supplementary medical foods given by mothers in Hong Kong. Early Hum Dev 17:157-163.
24. Tang XQ, Cao JG. 2004. Review on the pharmacological research of neferine. Chin Pharmacol Bull 20:8-10.
25. Wahed A, Pollard J, Wells A et al. 2003. Impaired protein binding of Chinese medicine Dan Shen in uremic sera and sera with hyperbilirubinemia: rapid assessment of total and free Dan Shen concentrations using the fluorescence polarization immunoassay for digoxin. J Clin Lab Anal 17:179-183. (Pubitemid 37128658)
26. Weisiger RA, Ostrow JD, Koehler RK et al. 2001. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem 276:29953-29960.
27. Wennberg RP, Ahlfors CE, Bhutani VK et al. 2006. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117:474-485. (Pubitemid 46071611)
28. WHO. 2002. WHO Traditional Medicine Strategy 2002-2005. WHO/EDM/TRM/2002.1. World Health Organization: Geneva.
29. Xu T, Cao H, Jin X. 2002. Study progress of clinical application of tetrahydropalmatine. Acta Univ Trad Med Sinen Pharmacol Shanghai 14:60-63.
30. Yan XH, Li HD, Peng WX et al. 1997. Determination of sinomenine HCl in serum and urine by HPLC and its pharmacokinetics in normal volunteers. Acta Pharm Sin 32:620-624. (Pubitemid 127464987)
31. Yeung CY, Lee FT, Wong HN. 1990. Effect of a popular Chinese herb on neonatal bilirubin protein binding. Biol Neonate 58:98-103. (Pubitemid 20222316)
32. Yeung CY, Leung CS, Chen YZ. 1993. An old traditional herbal remedy for neonatal jaundice with a newly identified risk. J Paediatr Child Health 29:292-294. (Pubitemid 23228945)